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Open access under CC BThis study was designed to investigate whether the pattern of hypothalamic and splenic cytokine expres-
sion induced by peripheral administration of a bacterial lipopolysaccharide (LPS) is affected by prior
exposure to LPS derived from another bacterial strain. Injection of LPS from Salmonella enteritidis
(LPS2) alone resulted in increased hypothalamic gene expression of IL-1b, IL-6, TNFa, IL-1ra and IL-10.
However, pre-exposure to LPS derived from Escherichia coli (LPS1) 3 weeks before, signiﬁcantly attenuated
hypothalamic IL-1ra, IL-6 and IL-10 expression. IL-1b expression also tended to be lower. This pattern
contrasted with the robust cytokine expression in the spleen of LPS2-treated rats previously exposed
to LPS1, since pre-treatment with endotoxin resulted in a signiﬁcantly greater response of IL-1b and
IL-1ra to LPS2. Expression of TNFa and IL-10 also tended to be higher. Pre-treatment with LPS1 did not
signiﬁcantly affect themarked increase in corticosterone and adrenaline blood levels inducedby LPS2. Thus,
while endotoxin pre-exposure seemed not to induce a ‘‘tolerant” state in the periphery as judged by the
immune and endocrine parameters evaluated upon re-stimulation, expression of four of the six cytokines
measured was decreased in the hypothalamus. This is the ﬁrst demonstration that endotoxin priming
can differentially affect cytokine expression in the central nervous system and peripheral tissues when a
host is confronted with a second, acute, pro-inﬂammatory stimulus. These results may provide new
evidence for the involvement of cytokine pathways in the central nervous system inmodulating peripheral
inﬂammation and mediating cognitive and behavioural alterations during inﬂammatory diseases.
 2009 Elsevier Inc.Open access under CC BY license.1. Introduction
Lipopolysaccharide (LPS), an endotoxin derived from the cell
wall of Gram-negative bacteria, is an immunological stressor that
stimulates the activity of the hypothalamus–pituitary–adrenal
(HPA) axis (Harbuz, 2002) and the sympathetic nervous system
(SNS) (Zhang et al., 2000). LPS also induces a rapid inﬂammatory
reaction through the release of pro-inﬂammatory cytokines, a phe-
nomenon that has been associated with induction or exacerbation
of disease in rat models of chronic inﬂammation (Stimpson et al.,
1987; Yoshino et al., 1999). However, in contrast to this acute
inﬂammatory response, we have observed that a single injection
of LPS administered 3 weeks prior to the induction of adjuvant
arthritis (AA) in rats can confer resistance to inﬂammation (Harbuz
et al., 2002). In parallel to the effects on the HPA axis and SNS,
immunological challenge can activate other central pathways such
as cytokine networks. Rapid effects of acute injection of LPS on
hypothalamic cytokine expression and protein content are well: +44 117 3313029.
ssop).
Y license.documented (Breder et al., 1994; Laye et al., 1994; Pitossi et al.,
1997; Wong et al., 1997; Quan et al., 1998; Castanon et al., 2004;
Roche et al., 2006). In addition to this acute stimulation of central
cytokine expression, we have recently reported that IL-1b and IL-6
gene expression is increased in the hypothalamus following immu-
nization of rats with arthritogenic type II collagen antigens.
Increased expression of these cytokines is maintained for 2–3
weeks, but is no longer detected when symptoms of arthritis are
overtly expressed (del Rey et al., 2008). Furthermore, administra-
tion of a single dose of IL-1b, a cytokine induced by LPS administra-
tion, results in a long lasting (weeks) increased responsiveness of
the HPA axis (Schmidt et al., 2001). However, the potential for
pre-treatment with LPS to induce long-term changes in SNS activ-
ity and in cytokine expression in the hypothalamus has not been
studied. The investigation of this possibility is relevant considering
that the brain can affect immune processes and mechanisms that
underlie cognitive and behavioural alterations during inﬂamma-
tory diseases.
We have previously observed that the protective effect of prior
exposure to LPS on induction of adjuvant-induced arthritis in rats
is associated with an alteration in peripheral cytokine secretion
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here was to study if prior exposure to LPS affects cytokine gene
expression in the hypothalamus and corticosterone and catechol-
amine output when a host is confronted with a second, acute,
pro-inﬂammatory insult. Furthermore, these studies represent a
ﬁrst attempt to investigate whether the protective effect of LPS
on experimentally induced arthritis may also involve changes in
brain-borne cytokines. Following the previous protocol (Richards
et al., 2006), rats received LPS derived from Escherichia coli fol-
lowed 3 weeks later by a second injection of endotoxin derived
from Salmonella enteritidis. There were several reasons to choose
this combination of LPS from different Gram-negative bacteria as
well as the time schedule of exposure. Firstly, we wished to follow
an established protocol which demonstrated that, when these two
endotoxins were injected 3 weeks apart, the second endotoxin
challenge robustly stimulated blood levels of TNFa and IL-10,
and also HPA axis activity (Richards et al., 2006). Therefore there
was no evidence that an endotoxin from an alternative source
was acting as a homotypic stressor, thus inducing HPA axis habit-
uation (Dallman et al., 2002). Secondly, we wanted to use a second
stimulus that also acts via Toll 4-like receptors to avoid the possi-
bility that stimulation of other Toll-like receptors would induce the
production of cytokines different from those triggered by the ﬁrst
Toll 4 agonist (Ghosh et al., 2006). Finally, while the effects of
LPS on the HPA axis and the SNS are rather well known and estab-
lished, there is still controversy regarding endocrine responses
induced by stimuli of other Toll-like receptors (Myers et al., 2001).
Thus, using this established model, expression of the same cyto-
kines was evaluated in the hypothalamus and in the spleen to com-
pare central and peripheral responses to LPS pre-treatment.
Peripheral catecholamine output and corticosterone blood levels
were also determined in parallel.2. Materials and methods
2.1. Animals
Adult male Wistar rats (200–225 g; Bantin & Kingman, UK)
were housed under standard conditions of temperature and
humidity with 12 h:12 h light/dark cycle, lights on at 07.00 h. Ani-
mals were fed laboratory chow and water ad libitum throughout
experiments. The care and use of the animals was performed in
accordance with the Animals (Scientiﬁc Procedures) Act UK 1986.
2.2. Experimental procedures
Groups of rats (n = 8) received endotoxin-free saline (SAL;
0.5 ml) or lipopolysaccharide (LPS1; Sigma, UK, serotype E. coli
055:B5; 1 mg/kg body weight in 0.5 ml of saline) injected intraper-
itoneally between 8:00 and 8:30 a.m. and returned to their home
cages. This dose of LPS of the 055:B5 serotype is sufﬁcient to stim-
ulate the HPA axis with no apparent effects on animal behaviour,
e.g., locomotion, fur appearance, exploratory behaviour (Conde
et al., 1999). Twenty-one days later, both groups of animals were
injected i.p. with LPS derived from S. enteritidis (LPS2; 1 mg/kg body
weight, 100K4088, Sigma, UK) in 0.5 ml of saline between 8:00 and
8:30 a.m. (SAL + LPS2; and LPS1 + LPS2). The dose of Salmonella
enteritidis LPS that was used in the present study has no observa-
ble behavioural effects. A control group of rats were injected with
endotoxin-free saline, and they received a second injection of sal-
ine on day 21 (SAL + SAL). We did not include the control group
LPS1 + SAL because we have previously observed that blood cyto-
kine and hormone levels in this control group after 21 days were
no different to those in the group SAL + SAL (Richards et al.,
2006), i.e., were all basal. Similarly, gene expression of severalcytokines (IL-1b, IL-6, TNFa and IFN-c) in several brain regions
and in the spleen following administration of LPS were decreasing
or had returned to basal after 6 h (Pitossi et al., 1997). Although
these studies were performed in mice, we considered it to be extre-
mely unlikely that cytokine gene expression in the hypothalamus
or spleen of rats would still be elevated 21 days following LPS.
Following the second injection, rats were returned to their home
cages and sacriﬁced by decapitation 4 h later. Trunk blood was
collected in heparinised tubes, centrifuged, and the plasma was
aliquoted and stored at80 C until used for corticosterone and cat-
echolamine measurements. Brains and spleens were removed and
immediately frozen on dry ice. The hypothalamus (optic chiasm lat-
erally,mammillary bodies posteriorly, fornix laterally and top of the
third ventricle) was dissected from the rest of the brain and tissues
were stored at 80 C for cytokine mRNA analysis.
2.3. Corticosterone and catecholamine measurements
Corticosterone plasma concentrations were determined by RIA,
as previously described (Besedovsky et al., 1991). Noradenaline
(NA), adrenaline (A) and dopamine (DA) concentrationswere deter-
mined byHPLC as previously described (del Rey et al., 2008). Brieﬂy,
plasma samples were treated with 0.4 M perchloric acid and under-
went a puriﬁcation step with alumina adsorption prior to HPLC
determination. Aliquots of the supernatant were injected into an
HPLC system with serially connected electrochemical and ﬂuores-
cence detection. Peaks were quantiﬁed by peak height evaluation
with an evaluation software (ChromeleonVersion 6.01, Dione, USA).
2.4. RNA extraction and RT-PCR
These procedures were performed as previously described (Apk-
arian et al., 2006). Brieﬂy, total RNA extractionwas performed using
TRIzol Reagent (Invitrogen Life Technologies) according to a stan-
dard protocol (Chomczynski and Sacchi, 1987). The RNAwas treated
with 2U DNaseI (Epicentre technologies) in 10 Buffer Y+/Tango
(MBI Fermentas) followed by puriﬁcation using RNeasy Mini Spin
Columns (Qiagen) according to the manufacturer’s instruction and
eluted in 30 ll RNase freewater. Reverse transcription (RT)was per-
formed from 1 lg total RNA using 40U MMLV reverse transcriptase
(Invitrogen Life Technologies) and 0.5 mg/ml oligop(dT) 12-18-pri-
mer (Amersham Biosciences) in a total volume of 20 ll. RT was per-
formed at 42 C for 60 min and 70 C for 15 min. PCRwas performed
in a volume of 25 ll with the ABI PRISM 7700 Sequence Detection
System (PE Applied Biosystems) using optical reaction tubes. A
master mix was prepared containing 12.5 ll 2 PCR buffer
(100 mM KCl, 20 mM Tris–HCl pH 8.3, 0.02 mM EDTA, 0.1% gelatin,
0.02% Tween-20), nucleotides dATP, dCTP, dGTP (200 lM each),
400 lM dUTP, 1.0 ll 25 mM MgCl2, 0.625U AmpliTaqGold (PE Ap-
plied Biosystems), 0.25U Uracil- DNA-Glycosylase (New England
Biolabs), 200 nMof eachprimer, 100 nMof the correspondingprobe,
and Rox dye in a ﬁnal concentration of 300 nM (TIB MOLBIOL). The
master mix (21 ll) were added to each well of 96 well-plates fol-
lowed by addition of 4 ll cDNA. All PCR reactions were performed
two to four times induplicatesusing the following conditions: initial
50 C for 2 min and 95 C for 10 min, followed by 40 cycles at 95 C
for 15 s and 60 C for 1 min.
2.5. Relative quantitation of PCR products
Primer and ﬂuorogenic probes were designed using the auto-
mated primer analysis software, Primer Express (PE Applied
Biosystems). Primer and probes were chosen to bind in different
exons or to span exon junctions to prevent ampliﬁcation of geno-
mic DNA. The forward and reverse primers, and internal probe
sequences for each cytokine and the house keeping genes are given
Table 1
Primer and probe sequences used to quantify cytokine and reference gene expression.
Accession Name Forward Primer Probe Reverse Primer
X06483 rpL32 TGTCCTCTAAGAACCGAAAAGCC TCGTAGAAAGAGCAGCACAGCTGGCC CGTTGGGATTGGTGACTCTGA
X02231 GAPDH ACGGGAAACCCATCACCAT TTCCAGGAGCGAGATCCCGTCAAG CCAGCATCACCCCATTTGA
E05490 IL-1ß ACCCAAGCACCTTCTTTTCCTT TCTTTGAAGAAGAGCCCGTCCTCTGTGACT TGCAGCTGTCTAATGGGAACAT
X66539 TNFa GGTGATCGGTCCCAACAAGGA TGGCCCAGACCCTCACACTCAGATCA CACGCTGGCTCAGCCACTC
NM_012589 IL-6 GACAGTGCATCATCGCTGTTCATA CAGAATTGCCATTGCACAACTCTTTTCTCATTT AGTCGGAGGCTTAATTACATATGTTC
AF010466 IFNc GCTATGGAAGGAAAGAGCCTCC ATATCTGGAGGAACTGGCAAAAGGACGGT GATGGCCTGGTTGTCTTTCAA
M63101 IL-1ra CTCTCCTTCTCATCCTTCTGTTTC AAGATGCAAGCCTTCAGAATCTGGGATACT AGCAATGAGCTGGTTGTTCCTC
X60675 IL-10 GGTTGCCAAGCCTTGTCAGAA TGCGACGCTGTCATCGATTTCTCCC GCTCCACTGCCTTGCTTTTATT
778 A.del Rey et al. / Brain, Behavior, and Immunity 23 (2009) 776–783in Table 1 (for rpL32 (Wang et al., 2000); for TNFa, (Fink et al.,
1998); for IL-10 (Overbergh et al., 2003). The comparative CT
method, previously described (Livak et al., 1995) was used to cal-
culate relative gene expression data since we have determined in
preliminary experiments that the ampliﬁcation efﬁciencies of the
target genes and the reference genes (rpL32 and GAPDH) are
approximately the same. Thus, cytokine mRNA levels were normal-
ized to the rpL32 (hypothalamus) and GAPDH (spleen) mRNA
levels in each sample. Unless otherwise indicated, the value of sal-
ine-injected animals was arbitrarily set at 1.0, and the results of
the groups (SAL + LPS2) and (LPS1 + LPS2) expressed as fold-change.
To compare hypothalamic and splenic cytokine expression follow-
ing re-exposure to LPS (LPS1 + LPS2 group) with the expression
induced by a single injection of endotoxin, the value of
(SAL + LPS2)-injected animals was arbitrarily set at 1.0, and the
results of the (LPS1 + LPS2) group expressed as fold-change in each
corresponding tissue.
2.6. Statistical analysis
Results are expressed as mean ± SEM. Data were analyzed using
one-way ANOVA followed by Fisher’s test for multiple compari-
sons. Differences were considered signiﬁcant when p was <0.05.
3. Results
3.1. Corticosterone and catecholamine blood concentrations
Corticosterone plasma concentrations were increased in
response to the injection of LPS2 in both groups of rats that
received LPS (SAL + LPS2 and LPS1 + LPS2) compared to the SAL + SAL
controls, but no signiﬁcant difference was observed between them
(Fig. 1). NA plasma concentrationswere unaffected by LPS, but a sig-
niﬁcant increase in A, and decrease in DA, concentrations was
observed in response to LPS2 (Fig. 1) compared to the SAL + SAL con-
trols. There were no signiﬁcant differences between the SAL + LPS2
and LPS1 + LPS2 groups for any catecholamine measured.
3.2. Cytokine gene expression in the hypothalamus
Signiﬁcant increases were observed in mRNA for all cytokines
measured in the SAL + LPS2 and LPS1 + LPS2 groups when compared
with SAL + SAL controls, with the exception of IFNc, for which the
difference did not reach statistical signiﬁcance (Fig. 2). Pre-treat-
ment with LPS1 resulted in signiﬁcantly less IL-1ra, IL-6 and IL-10
gene expression in the LPS1 + LPS2 group compared to the SAL + LPS2
group. A decrease in IL-1bmRNA, and increase in TNFamRNA, were
observed in the LPS1 + LPS2 group compared to the SAL + LPS2 group,
but the differences did not reach statistical signiﬁcance.
3.3. Cytokine gene expression in the spleen
Injection of LPS2 alone resulted in signiﬁcant increases in IL-1ra,
TNFa, IFNc, IL-6 and IL-10 mRNA in the spleen when compared tothe SAL + SAL controls (Fig. 3). The increase in IL-1b mRNA levels
induced by LPS2 was nearly statistically signiﬁcant (p = 0.055 vs.
Sal + Sal). With the only exception of IFNc, exposure to LPS1 3
weeks prior to LPS2 administration resulted either in a similar
(IL-6, TNFa and IL-10) or even increased (IL-1b and IL-1ra) cytokine
gene expression in the spleen when compared to those of rats that
received LPS2 only.
3.4. Re-exposure to LPS differentially affects cytokine gene expression
in the hypothalamus and in the spleen
Differential effects of a second LPS challenge on cytokine
expression in the hypothalamus and spleen are summarized in
Fig. 4. To compare the impact that prior exposure to LPS (LPS1)
has on the capacity of the hypothalamus and the spleen to express
pro- and anti-inﬂammatory cytokines when a host is confronted
with a second pro-inﬂammatory stimulus (LPS1 + LPS2), the results
of the group (SAL + LPS2) in both tissues were set at 1.0 and ex-
pressed as fold-change (Fig. 4). Thus, values lower than 1 indicate
that re-exposure to LPS results in less gene expression, and values
higher than 1 in more expression, of a given cytokine in a given tis-
sue as compared to one single exposure. The results show that re-
exposure to LPS differentially affects the expression of most of the
cytokines evaluated in the hypothalamus and in the spleen. While
re-exposure to LPS resulted in more IL-1b, TNFa, IFNc, IL-1ra, and
IL-10 gene expression in the spleen, the expression of IL-1, IL-1ra
and IL-10 was decreased in the hypothalamus. Comparatively,
LPS re-exposure also resulted in less IL-6 and TNFa expression in
the hypothalamus than in the spleen, but the differences did not
reach statistical signiﬁcance. IFNc expression showed a larger var-
iance between animals than the other cytokines and it was similar
in both organs. The maximal differences were observed in the two
anti-inﬂammatory cytokines, IL-1ra and IL-10. In both cases, the
spleen showed more than two-fold increased expression of mRNA
transcripts than the hypothalamus.4. Discussion
This is the ﬁrst report that prior exposure to LPS can alter gene
expression of cytokines in the hypothalamus of rats when they are
challenged with a second injection of LPS derived from another
Gram-negative bacteria. A further novel observation is that, in con-
trast to the general decrease in hypothalamic cytokine expression
in LPS-pre-treated rats, an increase in most cytokines measured
was observed in the spleen.
In response to a single injection of LPS, we observed increased
hypothalamic expression of the pro-inﬂammatory cytokines IL-
1b, IL-6, and TNFa, which is consistent with the acute cytokine
response to LPS previously reported (Breder et al., 1994; Laye
et al., 1994; Pitossi et al., 1997; Wong et al., 1997; Quan et al.,
1998; Castanon et al., 2004). The expression of the anti-inﬂamma-
tory cytokines IL-10 and IL-1ra was also increased. The dose of LPS
that we employed was less than that required to induce sickness
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Fig. 1. Corticosterone and catecholamine levels in plasma following one or two injections of LPS from different sources. Groups of rats received endotoxin-free saline (SAL) or
lipopolysaccharide from Escherichia coli (LPS1) injected intraperitoneally. Twenty-one days later, both groups of animals were injected i.p. with LPS derived from Salmonella
enteritidis (LPS2) (SAL + LPS2 and LPS1 + LPS2). A third group of rats injected with endotoxin-free saline 21 days before, received a second injection of saline (SAL + SAL).
Animals were sacriﬁced 4 h after the second injection. Corticosterone and catecholamine levels were determined in plasma. Bars indicate the mean ± SEM of determinations
performed in 7–8 animals per group. *p < 0.05 vs. SAL + SAL.
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ously reported that even double the dose used in this study does
not disrupt the blood–brain barrier in rats (Bickel et al., 1998).
Therefore, it is not likely that the cytokine responses that we
observed following a single injection of LPS were the consequence
of an inﬂammatory response to tissue damage caused by disrup-
tion of the blood–brain barrier or to sickness behaviour, which
can be induced by higher doses of LPS or similar doses of a different
serotype (Castanon et al., 2001).
Exposure of the LPS-pre-treated rats to a second injection of LPS
also resulted in increased expression of IL-1b, IL-6, TNFa, IL-1ra
and IL-10 in the hypothalamus when compared to rats that re-
ceived the vehicle alone. However, although LPS-pre-treatment
did not signiﬁcantly affect hypothalamic TNFa and IFNc expres-
sion, it signiﬁcantly decreased the expression of IL-6, IL-10 and
IL-1ra when compared to non-pre-treated rats. IL-1b gene expres-
sion also tended to decrease, but no statistical signiﬁcance was
reached (p = 0.117). In contrast to the hypothalamus, re-exposure
to LPS resulted in increased splenic IL-1b and IL-1ra expression
when compared to a single endotoxin injection, while the increase
in IL-6, TNFa and IL-10 was comparable whether rats had been
pre-treated or not.
Using the same model as in this study, we have previously re-
ported that re-exposure to LPS results in decreased blood levels
of IFNc and IL-6, without affecting TNFa and IL-10 concentrations(Richards et al., 2006). This pattern of circulating cytokine levels is
essentially consistent with an anti-inﬂammatory milieu that might
explain the protective effect of the endotoxin on the adjuvant
arthritis model (Harbuz et al., 2002). On one hand, over-expression
of IL-1ra, a tendency to decreased IFNc expression and no changes
in IL-10 expression in the spleen of rats re-exposed to LPS is in line
with our previous report. On the other hand, a second inﬂamma-
tory insult increased the gene expression of the pro-inﬂammatory
cytokine IL-1, while it did not signiﬁcantly affect the expression of
IL-6 and TNFa. Tentative explanations for the apparent discrepancy
in IL-6, which was decreased in the circulation but no changes
were observed in splenic gene expression, could be that a second
endotoxin challenge results in inhibition of cytokine production
at translational levels or in its secretion by immune cells. In addi-
tion, a reduction in the concentration of pro-inﬂammatory cyto-
kines in the circulation may be the result of effects in all
immune cell compartments while the studies reported here were
restricted to the evaluation of splenic cytokine expression. In cer-
tain models of endotoxin tolerance, for example, it has been shown
that splenic mRNA IL-1 levels are increased following LPS injection,
but that the spleen is not essential for the increase in serum IL-1
concentration (Zuckerman et al., 1991). In any case, at least at gene
level, our data demonstrate that the hypothalamus and the spleen
respond with a different pattern of cytokine expression to a second
pro-inﬂammatory insult. As mentioned, the maximal relative
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Fig. 2. Cytokine gene expression in the hypothalamus following one or two injections of LPS from different sources. The hypothalami of the rats used for the determinations
shown in Fig. 1 were dissected from brains frozen on dry ice immediately after decapitation, and stored at 80 C until used for cytokine mRNA determinations by real time
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Fig. 3. Cytokine gene expression in the spleen following one or two injections of LPS from different sources. The spleen of the rats used for the determinations shown in Figs. 1
and 2 was dissected immediately after decapitation, frozen and stored at 80 C until used for cytokine mRNA determinations by real time RT-PCR. Bars indicate the
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anti-inﬂammatory cytokines, IL-1ra and IL-10.
Very little has been published on the impact of previous expo-
sure to LPS on cytokine gene expression in the brain following re-
exposure to LPS. Previous reports are largely related to the phe-
nomenon of ‘‘endotoxin tolerance”, a term which is frequently
used to deﬁne a condition in which re-exposure to a second, much
higher, dose of endotoxin after a short time is associated with
blunted peripheral immune and HPA axis responses (Roth et al.,
1994; Faggioni et al., 1995; Hadid et al., 1995, 1996; Takemura
et al., 1997; Grinevich et al., 2001; Beishuizen and Thijs, 2003;
Chen et al., 2005). Mice pre-treated with LPS showed attenuated
brain and serum TNFa responses to a second injection of LPS 4 days
later (Faggioni et al., 1995). Other authors reported that central
TNFa and IL-1b expression were similar in response to a high dose
of LPS in pre-treated and non-pre-treated rats over a 9 day exper-
imental period while IL-6 mRNA was decreased in the pre-treated
group (Chen et al., 2005). In both these studies, cytokine mRNA
was measured in whole brain extracts. The effects of endotoxin tol-
erance on cytokine release by immune cells and HPA axis activity
have been reported up to 28 days following initial exposure to
endotoxin (Roth et al., 1994; Hadid et al., 1995, 1996; Takemura
et al., 1997; Grinevich et al., 2001). In accord with our previous re-
sults (Richards et al., 2006), the data reported here also show that
in the model we have used, prior exposure to LPS does not seem to
result in ‘‘peripheral tolerance” when animals are exposed again to
an endotoxin from a different bacterial source. Probably the stron-
gest argument against the possibility that our ﬁndings reﬂect the
development of endotoxin tolerance is the fact that priming with
LPS 21 days prior to a second LPS challenge resulted in similar in-
creases of IL-6, TNFa and IL-10 gene expression in the spleen, and
corticosterone and adrenaline levels in blood, and even increased
splenic IL-1b and IL-1ra gene expression, compared to a single
LPS injection. If there is any ‘‘tolerance” induction in the model
we have used, this is only observed at hypothalamic level, with
decreased IL-1b, IL-1ra, IL-6 and IL-10 gene expression.
In addition to activating the HPA axis, a single dose of LPS also
stimulates the SNS (Conde et al., 1999; Zhang et al., 2000). Weobserved similar effects of LPS on plasma adrenaline, while no
effect was observed on noradrenaline. The decrease in dopamine
levels observed in parallel might reﬂect an increase in adrenaline
turnover in the adrenal gland. Peripheral catecholamines have been
shown to modulate the effects of LPS on peripheral immune
functions (Delrue-Perollet et al., 1995). Therefore, the fact that the
response of the SNS is maintained after re-exposure to LPS would
be an additive component to the anti-inﬂammatory cytokinemilieu
that we have previously detected. Taken together, the preserved
neuro-endocrine response (increase of adrenaline and glucocorti-
coid blood levels) to a second pro-inﬂammatory insult may
contribute to prevent the induction of inﬂammatory disease in rats
pre-exposed to LPS (Shanks et al., 2000; Harbuz et al., 2002) or IL-1
(Huitinga et al., 2000).
Awide range of functions have been ascribed to cytokineswithin
thebrain (Besedovsky anddel Rey, 2008). In addition to the evidence
that peripherally immune-derived cytokines can trigger neuro-
endocrine responses during infection and inﬂammation, several
non-immune functions of cytokines such as TNFa, IL-1b and IL-6
synthesised within the CNS in the absence of disease have been de-
scribed. For example, it is well documented that expression of cyto-
kines within a physiologic range is relevant for learning, memory
and behaviour, neuroprotection and the control of neuro-endocrine
functions (Besedovsky and del Rey, 2007; Gosselin and Rivest, 2007)
and it may be inappropriate to categorize these CNS cytokines as
pro- or anti-inﬂammatory in the classic immune sense, particularly
in the lower concentrations inwhich they are found in the ‘‘healthy”
CNS compared to immune tissues. On the other hand, over-expres-
sion of brain-borne cytokines can mediate alterations in cognitive
and behavioural mechanisms that occur during peripheral autoim-
mune/inﬂammatory pathologies. Our ﬁndings that sequential pro-
inﬂammatory insults result in decreased expression of IL-1ra and
IL-10, cytokines that canmodulate the effect of inﬂammatorymedi-
ators in the hypothalamus, may further contribute to aggravate the
alterations referred to. For example, the effectsof IL-1bonserotoner-
gic pathways that are involved in depressive symptoms are well
known (for review see, Besedovsky and del Rey, 2008). Differential
central cytokine responses to a single or repeated LPS stressor may
782 A.del Rey et al. / Brain, Behavior, and Immunity 23 (2009) 776–783also conferpotential for aparacrine inﬂuenceof cytokineswithin the
hypothalamus, for example, on CRH and/or AVP expression for ﬁne-
tuning ofHPA axis activity, which can in turn affect the immune sys-
tem through catecholamine and glucocorticoid release. In fact cen-
tral administration of low doses of IL-1, which are not effective in
theperiphery, results in immunosuppression that is at least partially
dependent on an increased secretion of adrenal hormones (Sundar
et al., 1989).
One possibility to interpret the results reported here is that the
decrease in anti-inﬂammatory cytokines in the brain is not the
cause but the consequence of a blunted peripheral inﬂammatory
response. Indeed, we and others have previously shown that the
brain, particularly the hypothalamus, can sense ongoing immune
responses (Besedovsky et al., 1983; Furukawa et al., 2004; for
review see Besedovsky and del Rey, 1996) and, when the immune
response is of sufﬁcient magnitude, a neuro-endocrine immuno-
regulatory ‘‘answer” is elicited. We have also hypothesized that
the pattern of central expression of cytokines is a way to codify
and register what type of peripheral immune response is in course.
This way of central representation of immune system activity
would constitute a kind of ‘‘immune homunculus” in the CNS
(Besedovsky and del Rey, 2001). The fact that, 3 weeks after a ﬁrst
stimulus, a second inﬂammatory challenge with an LPS from a dif-
ferent bacterial origin elicits a change in the pattern of expression
of cytokines in the hypothalamus, suggests that a kind of ‘‘mem-
ory” is stored in the brain. We speculate that the reduction in cyto-
kine expression in the hypothalamus reﬂects the way by which the
brain” remembers” a previous inﬂammatory insult.
While, from these data, we cannot draw functional conclusions
about effects of central cytokines, the data justify further studies
of hypothalamic cytokine expression in animal models of ‘‘periph-
eral” inﬂammatory pathologies. In particular, the inﬂuence of
prior exposure to pro-inﬂammatory agents on central cytokine
expression may provide insights into the relevance of effects of
hypothalamic cytokines on CNS and neuro-endocrine functions
during remission/relapse episodes of peripheral inﬂammatory
chronic diseases and on the neuropsychiatric components of these
pathologies.
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